CLINICAL AND PHARMACOLOGICAL STUDY OF HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN PATIENTS WITH ADVANCED BREAST-CANCER

被引：0
|
作者：
BECHER, R [1 ]
MILLER, AA [1 ]
GERHOLD, U [1 ]
HOFFKEN, K [1 ]
SCHMIDT, CG [1 ]
机构：
[1] UNIV ESSEN GESAMTHSCH KLINIKUM,W DEUTSCH TUMORZENTRUM,INNERE CLIN & POLICLIN,TUMORFORSCH,D-4300 ESSEN 1,FED REP GER
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1985年 / 26卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：191 / 191
页数：1
相关论文
共 50 条
  • [31] RANDOMIZED TRIAL OF LOW-DOSE VERSUS HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN THE INDUCTION TREATMENT OF POSTMENOPAUSAL PATIENTS WITH ADVANCED BREAST-CANCER
    CAVALLI, F
    GOLDHIRSCH, A
    JUNGI, F
    MARTZ, G
    MERMILLOD, B
    ALBERTO, P
    JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (05) : 414 - 419
  • [32] HIGH-DOSE VERSUS LOW-DOSE ORAL MEDROXYPROGESTERONE ACETATE (MPA) IN ADVANCED BREAST-CANCER - A RANDOMIZED TRIAL
    GALLAGHER, CJ
    MCKINNA, JA
    CAIRNDUFF, F
    SMITH, IE
    BRITISH JOURNAL OF CANCER, 1987, 56 (02) : 213 - 213
  • [33] HORMONE THERAPY IN ADVANCED BREAST-CANCER - COMPARISON BETWEEN HIGH-DOSE MEDROXYPROGESTERONE ACETATE (MAP) AND TAMOXIFEN (TMX)
    PANNUTI, F
    MARTONI, A
    FRUET, F
    CRICCA, A
    CANCER TREATMENT REPORTS, 1979, 63 (07): : 1219 - 1219
  • [34] HIGH-DOSE MEDROXYPROGESTERONE ACETATE VERSUS OOPHORECTOMY AS 1ST-LINE THERAPY OF ADVANCED BREAST-CANCER IN PREMENOPAUSAL PATIENTS
    MARTONI, A
    LONGHI, A
    CANOVA, N
    PANNUTI, F
    ONCOLOGY, 1991, 48 (01) : 1 - 6
  • [35] CYCLICAL USE OF TAMOXIFEN AND HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ADVANCED ESTROGEN-RECEPTOR POSITIVE BREAST-CANCER
    GUNDERSEN, S
    KVINNSLAND, S
    LUNDGREN, S
    KLEPP, O
    LUND, E
    BORMER, O
    HOST, H
    BREAST CANCER RESEARCH AND TREATMENT, 1990, 17 (01) : 45 - 50
  • [36] PHARMACOKINETIC AND PHARMACODYNAMIC BASIS FOR THE TREATMENT OF METASTATIC BREAST-CANCER WITH HIGH-DOSE MEDROXYPROGESTERONE ACETATE
    BLOSSEY, HC
    WANDER, HE
    KOEBBERLING, J
    NAGEL, GA
    CANCER, 1984, 54 (06) : 1208 - 1215
  • [37] HIGH-DOSE ORAL MEDROXYPROGESTERONE ACETATE (MPA) FOR THE TREATMENT OF METASTATIC BREAST-CANCER (MBC)
    HORTOBAGYI, G
    FRYE, D
    BUZDAR, A
    YAP, HY
    SCHELL, F
    BLUMENSCHEIN, G
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1982, 23 (MAR): : 148 - 148
  • [38] HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN ADVANCED OVARIAN-CANCER
    QUINN, MA
    ROME, RM
    GRANT, P
    PLANNER, RS
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1991, 1 (05) : 239 - 241
  • [39] HIGH-DOSE MEGESTROL-ACETATE IN THE TREATMENT OF ADVANCED BREAST-CANCER
    TCHEKMEDYIAN, NS
    TAIT, N
    ABRAMS, J
    AISNER, J
    SEMINARS IN ONCOLOGY, 1988, 15 (02) : 44 - 49
  • [40] HIGH-DOSE MEDROXYPROGESTERONE ACETATE IN PATIENTS WITH ADVANCED RENAL ADENOCARCINOMA
    DOBERAUER, C
    BECHER, R
    KURSCHEL, E
    ANDERS, C
    KLOKE, O
    BLUT, 1987, 55 (04): : 278 - 278
12345